KR20190088171A - 1,2-Diol type polyol derivative compound and preparation method thereof and anti-microbial composition containing it - Google Patents

1,2-Diol type polyol derivative compound and preparation method thereof and anti-microbial composition containing it Download PDF

Info

Publication number
KR20190088171A
KR20190088171A KR1020180006364A KR20180006364A KR20190088171A KR 20190088171 A KR20190088171 A KR 20190088171A KR 1020180006364 A KR1020180006364 A KR 1020180006364A KR 20180006364 A KR20180006364 A KR 20180006364A KR 20190088171 A KR20190088171 A KR 20190088171A
Authority
KR
South Korea
Prior art keywords
diol
derivative compound
polyol derivative
compound
present
Prior art date
Application number
KR1020180006364A
Other languages
Korean (ko)
Inventor
김경욱
Original Assignee
주식회사 에이비앤씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 에이비앤씨 filed Critical 주식회사 에이비앤씨
Priority to KR1020180006364A priority Critical patent/KR20190088171A/en
Publication of KR20190088171A publication Critical patent/KR20190088171A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/10Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/524Preservatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to a polyol derivative compound having a 1,2-diol structure represented by chemical formula 1, a method of preparing the same, and an anti-microbial composition containing the compound as an active ingredient. In the chemical formula: R1 is nitrogen (N) or sulfur (S); and R2 is OH or C2 alkyl. According to the present invention, the polyol derivative compound having a 1,2-diol structure represented by the chemical formula 1 exhibits excellent anti-microbial activities better than 1,2-hexanediol, which is known to have the best anti-microbial activity among polyols, thereby being effectively used as a preservative for a food product, a medicine, a cosmetic, and the like to prevent spoilage caused by microorganisms.

Description

1,2-디올 구조의 폴리올 유도체 화합물과 그 제조방법 및 이를 함유하는 항균 조성물 {1,2-Diol type polyol derivative compound and preparation method thereof and anti-microbial composition containing it}TECHNICAL FIELD The present invention relates to a polyol derivative compound having a 1,2-diol structure, a process for producing the same, and an antimicrobial composition containing the 1,2-diol structure and an antimicrobial composition containing the 1,2-

본 발명은 신규 항균 화합물에 관한 것으로서, 구체적으로는 화학식 1로 표시되는 1,2-디올 구조를 갖는 폴리올 유도체 화합물, 그 제조방법, 및 상기 화합물을 유효성분으로 함유하는 항균 조성물에 관한 것이다.The present invention relates to a novel antimicrobial compound, specifically to a polyol derivative compound having a 1,2-diol structure represented by the general formula (1), a process for producing the same, and an antimicrobial composition containing the compound as an active ingredient.

식품, 의약품, 화장품 등의 많은 제품들은 미생물에 의한 부패를 막아주는 방부제가 필수적이다. 특히 화장품의 경우는 유통기간이 상대적으로 길고, 화장품안에 미생물의 영양원으로 사용될 수 있는 물질을 다량으로 함유하고 있다. 또 수분이 존재하므로 미생물이 쉽게 번식할 수 있는 최적의 조건이다. 이러한 문제점을 해결하고자 메틸 파라벤, 에틸 파라벤, 프로필 파라벤, 부틸 파라벤과 같은 파라벤류와 펜옥시 에탄올과 같은 방부제가 사용되고 있다 (등록 특허 : 10-1567299). 하지만 최근에는 이러한 방부제를 화장품에 적용하였을 때 피부 알러지를 유발하기도하고, 인체 내부에 축적되어 환경 호르몬으로서의 가능성과 같은 여러 가지 문제점을 유발한다는 보고가 있다.Many products such as foods, medicines, and cosmetics require preservatives that prevent microbial decay. Especially, cosmetics have a relatively long distribution period and contain a large amount of substances that can be used as a nutrient source of microorganisms in cosmetics. It is also an optimal condition for microbes to reproduce easily due to the presence of water. To solve these problems, parabens such as methylparaben, ethylparaben, propylparaben, butylparaben and preservatives such as phenoxyethanol have been used (registered patent 10-1567299). Recently, however, there have been reports that when these preservatives are applied to cosmetics, they cause skin allergies and accumulate in the human body, causing various problems such as the possibility of environmental hormones.

천연에는 다양한 항균 물질들이 존재한다. 천연항균성 물질에 대한 연구는 많은 연구자들에 의해 연구되었는 데 다양한 천연물로부터 분리된 알카로이드, 플라보노이드, 피토알렉신, 항균펩타이드, 키토산 등의 항균력을 갖는다고 보고되었다. 하지만 이러한 천연유래의 항균 물질들의 경우 기존의 합성 방부제와 비교하여 항균력이 떨어져서 실제 제품에 방부제로 사용되지 못하고 있다. There are various antimicrobial substances in nature. Research on natural antimicrobial substances has been studied by many researchers and has been reported to have antibacterial activity such as alkaloids, flavonoids, phytoalexins, antimicrobial peptides and chitosan isolated from various natural products. However, these natural-derived antimicrobials do not have antimicrobial activity compared to conventional synthetic preservatives and thus are not used as preservatives in actual products.

또 하나의 접근 방법은 글리세린, 1,3-부탄디올, 프로필렌 글라이콜과 같은 폴리올이다. 최근에 1,2-헥산디올 (이 파라벤류와 펜옥시 에탄올을 대체하는 방부제로 폭넓게 사용되고 있다 (등록 특허 : 10-1567299). 하지만 방부효능을 나타내기 위해서는 2.0% 이상의 고함량을 사용해야 한다는 제한점을 가지고 있다.Another approach is polyols such as glycerin, 1,3-butanediol, and propylene glycol. Recently, 1,2-hexanediol has been widely used as a preservative to replace parabens and phenoxyethanol (Registered Patent No. 10-1567299). However, it has a limitation of using a high content of 2.0% or more in order to exhibit preservative efficacy Have.

이러한 이유로 앞에서 언급한 고함량을 사용해야 하는 1,2-헥산디올을 포함한 폴리올의 문제점을 개선할 수 있는 신규 항균 화합물 개발에 대한 강력한 니즈가 존재한다.For this reason, there is a strong need for the development of novel antimicrobial compounds that can ameliorate the problems of polyols including 1,2-hexanediol, which must use the above-mentioned high contents.

이에, 본 발명자들은 상기 종래기술들의 문제점들을 극복하기 위하여 예의 연구노력한 결과, 화학식 1로 표시되는 1,2-디올 구조를 갖는 폴리올 유도체 화합물이 종래 1,2-헥산디올보다 우수한 항균력을 발휘하여 저함량으로도 방부효능을 나타낼 수 있음을 확인하고, 본 발명을 완성하게 되었다.The inventors of the present invention have conducted intensive researches to overcome the problems of the prior art. As a result, the inventors of the present invention have found that a polyol derivative compound having a 1,2-diol structure represented by Formula 1 exhibits superior antibacterial activity to 1,2- The present invention has been completed.

KRKR 10-156729910-1567299 BB

따라서, 본 발명의 주된 목적은 화학식 1로 표시되는 1,2-디올 구조를 갖는 폴리올 화합물 및 그 제조방법을 제공하는 것이다.Accordingly, a main object of the present invention is to provide a polyol compound having a 1,2-diol structure represented by the general formula (1) and a process for producing the same.

본 발명의 다른 목적은 상기 1,2-디올 구조를 갖는 폴리올 화합물을 유효성분으로 함유하는 항균 조성물을 제공하는데 있다.Another object of the present invention is to provide an antimicrobial composition containing the polyol compound having the 1,2-diol structure as an active ingredient.

본 발명자들은 항균력을 나타내는 다양한 폴리올 화합물들의 구조를 분석한 결과 이웃한 디올 구조 (1,2-디올)가 항균력을 나타내는 데 중요한 기능을 한다는 것을 알 수 있었다. 이러한 분석 결과를 바탕으로 1,2-디올 구조를 갖는 디올 화합물을 제조하여 기존의 폴리올 중에서 가장 좋은 효과를 나타내는 1,2-헥산디올과 비교하여 항균력을 측정하였다. 다음과 같은, 3-(2-Hydroxy-ethylamino)-propane-1,2-diol, 3-Butylamino-propane-1,2-diol, 3-Butylsulfanyl-propane-1,2-diol 을 제조하여 1,2-헥산디올과 항균력을 비교 연구한 결과 세 화합물 모두 1,2-헥산디올 보다 우수한 항균력이 나타남을 확인하고 본 발명을 완성하게 되었다.As a result of analyzing the structure of various polyol compounds exhibiting antibacterial activity, the present inventors have found that the neighboring diol structure (1,2-diol) plays an important role in exhibiting antibacterial activity. Based on the results of the analysis, a diol compound having a 1,2-diol structure was prepared, and the antibacterial activity was measured in comparison with 1,2-hexanediol which exhibited the best effect among the conventional polyols. 3-Butylamino-propane-1,2-diol and 3-Butylsulfanyl-propane-1,2-diol were prepared as follows. As a result of a comparative study of the antibacterial activity against 2-hexanediol, all of the three compounds showed superior antibacterial activity to 1,2-hexanediol and completed the present invention.

3-(2-Hydroxy-ethylamino)-propane-1,2-diol 화합물은 폴리머를 제조하기 위한 중간체로 사용된 예는 있지만 항균력은 측정된 예가 없다 (Reactive & Functional Polymers, 2007, 67, 936). 3-Butylamino-propane-1,2-diol 화합물의 제조방법은 알려져 있으나 이 화합물 역시 항균력을 확인한 예는 없다 (CN 101161632 A). 3-Butylsulfanyl-propane-1,2-diol 화합물은 윤활제 (Lubricant)의 조성물로는 사용된 예는 있지만 항균력을 나타내는 화합물로는 사용된 예가 없다 (US 4384967 A).Although there are examples of 3- (2-Hydroxy-ethylamino) -propane-1,2-diol used as intermediates for the preparation of polymers, there is no measured example of antibacterial activity (Reactive & Functional Polymers, 2007, 67, 936). 3-Butylamino-propane-1,2-diol compound is known, but there is no example of this compound (CN 101161632 A). The 3-Butylsulfanyl-propane-1,2-diol compound has been used as a composition of a lubricant but has not been used as a compound showing antibacterial activity (US 4384967 A).

본 발명의 한 양태에 따르면, 본 발명은 하기 화학식 1로 표시되는 1,2-디올 구조의 폴리올 유도체 화합물을 제공한다:According to one aspect of the present invention, there is provided a polyol derivative compound having a 1,2-diol structure represented by the following formula (1): < EMI ID =

[화학식 1] [Chemical Formula 1]

Figure pat00001
Figure pat00001

상기 식에서, R1은 나이트로전(N) 또는 설퍼(S) 이고, R2는 OH 또는 C2 알킬이다.Wherein R 1 is Nitrogen (N) or Sulfur (S) and R 2 is OH or C 2 alkyl.

본 발명의 다른 양태에 따르면, 본 발명은 다음 1 단계 반응을 포함하는 상기 화학식 1로 표시되는 1,2-디올 구조의 폴리올 유도체 화합물의 제조방법을 제공한다:According to another aspect of the present invention, there is provided a process for preparing a polyol derivative compound of the 1,2-diol structure represented by the above formula (1), which comprises the following first step reaction:

1) 에폭시 구조를 갖는 글리시돌(Glycidol) 또는 3-클로로-프로판-1,2-디올 (3-Chloro-propane-1,2-diol)과 과량의 에탄올 아민, 부틸아민, 또는 부탄티올을 반응시키는 단계.1) Glycidol or 3-Chloro-propane-1,2-diol with an epoxy structure and excess ethanolamine, butylamine, or butanethiol Lt; / RTI >

즉, 본 발명에 따른 상기 화합물은 하기 반응식 (1)과 같은 1단계 반응을 통하여 얻을 수 있다.That is, the compound according to the present invention can be obtained through a one-step reaction as shown in the following reaction formula (1).

[반응식 1][Reaction Scheme 1]

Figure pat00002
Figure pat00002

본 발명의 제조방법에 있어서, 상기 글리시돌 (Glycidol) 또는 3-클로로-프로판-1,2-디올 (3-Chloro-propane-1,2-diol)과 반응하는 에탄올아민, 부틸아민, 부탄티올의 비율은 1 : 1.5 내지 1 : 10 까지 모두 가능하며 이중 에탄올아민의 경우는 1 : 3 비율, 부닐아민의 경우는 1 : 1.1, 그리고 부탄티올의 경우는 1 : 1이 바람직하다.In the production process of the present invention, it is preferable to use ethanolamine, butylamine, butane (3-chloro-propane-1,2-diol), which reacts with glycidol or 3-chloro- The ratio of thiol can be from 1: 1.5 to 1:10, preferably 1: 3 in the case of ethanolamine, 1: 1.1 in the case of vanillamine, and 1: 1 in the case of butanethiol.

상기의 제조방법에 의해 얻어지는 화학식 1의 1,2-디올 구조를 갖는 폴리올 화합물의 구체적인 예로는 다음 화합물 1 내지 3을 들 수 있다,Specific examples of the polyol compound having a 1,2-diol structure of the formula (1) obtained by the above-mentioned production method include the following compounds 1 to 3,

화합물 1 : 3-(2-Hydroxy-ethylamino)-propane-1,2-diol,Compound 1: 3- (2-Hydroxy-ethylamino) -propane-1,2-diol,

화합물 2 : 3-Butylamino-propane-1,2-diol,Compound 2: 3-Butylamino-propane-1,2-diol,

화합물 3 : 3-Butylsulfanyl-propane-1,2-diol,Compound 3: 3-Butylsulfanyl-propane-1,2-diol,

본 발명의 다른 양태에 따르면, 본 발명은 상기 화학식 1로 표시되는 1,2-디올 구조의 폴리올 유도체 화합물을 유효성분으로 함유하는 항균 조성물을 제공한다. According to another aspect of the present invention, there is provided an antimicrobial composition comprising, as an active ingredient, a polyol derivative compound having a 1,2-diol structure represented by the general formula (1).

상기 화학식 1로 표시되는 1,2-디올 구조를 갖는 폴리올 화합물은 1,2-헥산디올과 비교하여 우수한 항균력을 나타내므로 화장품, 의약품, 식품의 항균제 또는 방부제로 사용될 수 있다. 본 발명에 있어서 "항균" 이란, 세균, 곰팡이, 효모 등의 오염 미생물에 대한 저항성을 의미하고, "방부”란 상기 세균, 곰팡이, 효모 등의 오염 미생물에 의한 부패를 방지하는 것을 의미한다.The polyol compound having the 1,2-diol structure represented by the above formula (1) exhibits an excellent antibacterial activity as compared with 1,2-hexanediol, and thus can be used as an antimicrobial agent or preservative in cosmetics, medicines and foods. In the present invention, "antibacterial" means resistance to contaminated microorganisms such as bacteria, fungi and yeast, and "preservative " means prevention of corruption caused by contaminated microorganisms such as bacteria, fungi and yeast.

본 발명의 시험예에 따르면, 본 발명에 따른 폴리올 화합물은 대장균 (Escherichia coli ; ATCC 8739), 슈도모나스 애루지노사 (Pseudomonus aeruginosa ; ATCC 9027), 스타필로코쿠스 아우레우스 (Staphylococcus aureus ; ATCC 6538), 칸디나 알비칸스 (Candida albicans ; ATCC 10231) 및 아스퍼질러스 니거 (Aspergillus niger ; ATCC 16404) 등의 박테리아, 효모 및 곰팡이에 대하여 우수한 항균력을 나타내었다.According to a test example of the present invention, the polyol compound according to the present invention is used in combination with Escherichia coli (ATCC 8739), Pseudomonas aeruginosa (ATCC 9027), Staphylococcus aureus (ATCC 6538) , Yeast and molds such as Candida albicans (ATCC 10231) and Aspergillus niger (ATCC 16404).

본 발명의 다른 양태에 따르면, 본 발명은 상기 화학식 1로 표시되는 1,2-디올 구조의 폴리올 유도체 화합물을 방부제로서 함유하는 피부 외용제 조성물을 제공한다.According to another aspect of the present invention, there is provided an external preparation for skin comprising a polyol derivative compound having a 1,2-diol structure represented by Formula 1 as a preservative.

본 발명에 있어서, 상기 화학식 1로 표시되는 1,2-디올 구조의 폴리올 유도체 화합물의 배합양은, 외용제 제품에 요구되는 항균력 또는 방부력의 정도에 따라서 당업자라면 적당하게 결정할 수 있고, 특별히 한정된 것은 아니다. 바람직하게는, 본 발명은 방부제로서 상기 화학식 1로 표시되는 1,2-디올 구조의 폴리올 유도체 화합물을 외용제 조성물 총 중량에 대하여 0.01 ∼ 20 중량% 함유하는 것을 특징으로 하는 외용제 조성물을 제공한다.In the present invention, the blending amount of the polyol derivative compound having the 1,2-diol structure represented by the above-mentioned formula (1) can be suitably determined by a person skilled in the art depending on the antimicrobial activity or the degree of the antifungal force required for the product for external application, . Preferably, the present invention provides a composition for external application comprising a polyol derivative compound having a 1,2-diol structure represented by Formula 1 as a preservative in an amount of 0.01 to 20% by weight based on the total weight of the composition.

본 발명에 있어서, 상기 피부 외용제는 유연화장수, 수렴화장수, 영양화장수, 아이크림, 영양크림, 마사지크림, 클린징크림, 클린징폼, 클린징워터, 파우더, 에센스, 팩 또는 연고 중 어느 하나의 형태로 제형화될 수 있으며, 그 제형이 특별히 한정되는 것은 아니다. 또한, 각각의 제형에 있어서, 다른 성분들은 기타 화장료 조성물의 종류 또는 사용목적 등에 따라 당업자가 어려움 없이 적의 선정하여 배합할 수 있다.In the present invention, the external preparation for skin may be in the form of any one of a softening agent, a convergent lotion, a nutritional lotion, an eye cream, a nutritional cream, a massage cream, a cleansing cream, a cleansing foam, a cleansing water, a powder, And the formulation is not particularly limited. Further, in the respective formulations, other ingredients may be selected and mixed without difficulty by those skilled in the art depending on the kind of the other cosmetic composition or the purpose of use.

또한 본 발명의 상기한 폴리올 화합물은 화장품 등의 외용제에서 피부유연제 (emollient), 보습제 (humectant) 또는 습윤제 (wetting agent) 등의 성분으로 외용제 조성물 내에 배합될 수 있다.In addition, the polyol compound of the present invention may be formulated into a composition for external application such as a skin softener (emollient), a humectant or a wetting agent in an external preparation such as a cosmetic.

이상 설명한 바와 같이, 본 발명에 따르면, 상기 화학식 1로 표시되는 1,2-디올 구조를 갖는 폴리올 유도체 화합물은 기존의 폴리올 중에서 가장 좋은 항균력을 나타낸다고 알려진 1,2-헥산디올보다 우수한 항균력을 나타내므로, 식품, 의약품, 화장품 등의 많은 제품들은 미생물에 의한 부패를 막아주는 방부제로서 효과적으로 사용될 수 있다.INDUSTRIAL APPLICABILITY As described above, according to the present invention, the polyol derivative compound having a 1,2-diol structure represented by the formula (1) exhibits superior antibacterial activity to 1,2-hexanediol known to exhibit the best antimicrobial activity among conventional polyols , Foods, medicines, and cosmetics can be effectively used as a preservative to prevent microbial decay.

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하기로 한다. 이들 실시예는 단지 본 발명을 예시하기 위한 것이므로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는다.Hereinafter, the present invention will be described in more detail with reference to Examples. These embodiments are only for illustrating the present invention, and thus the scope of the present invention is not construed as being limited by these embodiments.

[실시예 1] 3-(2-Hydroxy-ethylamino)-propane-1,2-diol의 제조[Example 1] Preparation of 3- (2-Hydroxy-ethylamino) -propane-1,2-diol

반응온도를 10℃ 이하로 유지하면서 글리시돌 (3.65g, 49.2mmol)을 에탄올아민 (9.15g, 149.8mmol)에 천천히 적가 하였다. 적가 한 후 반응혼합물을 10시간 동안 상온에서 교반하였다. 과량의 에탄올아민은 75℃ ~ 80 ℃ (1torr)에서 감압제거 한 후 원하는 최종생성물 (6.20g, 수율 93%)을 오일상으로 얻을 수 있었다. 생성물은 상온에 방치하면 viscous syrup 이 되었다.Glycidol (3.65 g, 49.2 mmol) was slowly added dropwise to ethanolamine (9.15 g, 149.8 mmol) while maintaining the reaction temperature below 10 ° C. After the dropwise addition, the reaction mixture was stirred at room temperature for 10 hours. The excess amount of ethanolamine is 75 < 0 > C to 80 The desired final product (6.20 g, yield 93%) was obtained in an oil phase after removal under reduced pressure at 1 (1 torr). The product was allowed to stand at room temperature to become a viscous syrup.

1H NMR(500MHz, D2O) δ 3.86 ~ 3.83(m, 1H), 3.72 ~ 3.52(m, 4H), 2.80 ~ 2.61(m, 4H). 1 H NMR (500 MHz, D 2 O)? 3.86-3.83 (m, 1H), 3.72-3.52 (m, 4H), 2.80-2.61 (m, 4H).

[실시예 2] 3-Butylamino-propane-1,2-diol 의 제조 [Example 2] Preparation of 3-Butylamino-propane-1,2-diol

N-부틸아민 (4.5g, 61.5mmol)을 에탄올(20mL)에 녹이고 글리시돌 (4.1g, 55.3mmol)을 서서히 가하였다. 반응혼합물은 상온에서 5시간 동안 교반 한 후, 에탄올은 감압하에 제거하였다. 반응혼합물을 130 ~ 135℃ (4torr)에서 증류하여 무색 액체상의 최종산물 (5.3g, 65% 수율)을 얻었다. N-Butylamine (4.5 g, 61.5 mmol) was dissolved in ethanol (20 mL) and glycidol (4.1 g, 55.3 mmol) was slowly added. The reaction mixture was stirred at room temperature for 5 hours and then the ethanol was removed under reduced pressure. The reaction mixture was distilled at 130-135 ° C (4 torr) to give the final product (5.3 g, 65% yield) as a colorless liquid.

1H NMR(500MHz, CDCl3) δ 3.73 ~ 3.66(m, 2H), 3.58 ~ 3.55(m, 1H), 2.90 ~ 2.75(brs, 3H), 2.75 ~ 2.70(m, 1H), 2.67 ~ 2.53(m, 3H), 1.45 ~ 1.42(m, 2H), 1.33 ~ 1.29(m, 2H), 0.88(t, 3H, J=6.5Hz). 1 H NMR (500MHz, CDCl 3 ) δ 3.73 ~ 3.66 (m, 2H), 3.58 ~ 3.55 (m, 1H), 2.90 ~ 2.75 (brs, 3H), 2.75 ~ 2.70 (m, 1H), 2.67 ~ 2.53 ( m, 3H), 1.45-1.42 (m, 2H), 1.33-1.29 (m, 2H), 0.88 (t, 3H, J = 6.5Hz).

[실시예 3] 3-Butylsulfanyl-propane-1,2-diol의 제조 [Example 3] Preparation of 3-Butylsulfanyl-propane-1,2-diol

글리시돌 (0.74g, 1.0mmol)과 1-부탄티올(0.90g, 1.0mmol)을 에탄올(10mL)에 녹이고 교반하면서 에탄올(10mL)에 녹인 수산화나트륨 (0.4g, 1.0mmol)용액을 상온에서 천천히 가하고 12시간 동안 교반하였다. 반응혼합물을 물 (100ml)로 희석하고 에틸아세테이트 (50ml)로 추출하였다. 유기층은 0.1N 염산용액, 포화 탄산수소나트륨 용액과 포화 염화나트륨 용액으로 씻은 후 무수황산마그네슘으로 건조하였다. 용매를 감압제거 한 후 관크로마토그래피로 분리하여 엷은 노란색 액체상의 생성물 (0.98g, 수율 59%)을 얻었다.A solution of sodium hydroxide (0.4 g, 1.0 mmol) dissolved in ethanol (10 mL) was added dropwise at room temperature while dissolving glycidol (0.74 g, 1.0 mmol) and 1-butanethiol (0.90 g, 1.0 mmol) Slowly added and stirred for 12 hours. The reaction mixture was diluted with water (100 ml) and extracted with ethyl acetate (50 ml). The organic layer was washed with 0.1N hydrochloric acid solution, saturated sodium hydrogencarbonate solution and saturated sodium chloride solution, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and the residue was purified by column chromatography to obtain the product (0.98 g, yield 59%) as a pale yellow liquid phase.

1H NMR(500MHz, CDCl3) δ 3.80 ~ 3.74(m, 2H), 3.60 ~ 3.55(m, 1H), 2.82(brs, 1H), 2.72 ~ 2.52(m, 4H), 2.07(brs, 1H), 1.60 ~ 1.57(m, 2H), 1.42 ~ 1.39(m, 2H), 0.91(t, 3H, J=7.5Hz). 1 H NMR (500MHz, CDCl 3 ) δ 3.80 ~ 3.74 (m, 2H), 3.60 ~ 3.55 (m, 1H), 2.82 (brs, 1H), 2.72 ~ 2.52 (m, 4H), 2.07 (brs, 1H) , 1.60-1.57 (m, 2H), 1.42-1.39 (m, 2H), 0.91 (t, 3H, J = 7.5 Hz).

[시험예 1] 항균력 시험[Test Example 1]

실시예 1 - 3 에서 얻어진 1,2-디올 구조의 폴리올 화합물의 항균력을 1,2-헥산디올과 비교하여 측정하였다. 항균력 측정 시험은, 대장균 (Escherichia coli ; ATCC 8739), 슈도모나스 애루지노사 (Pseudomonus aeruginosa ; ATCC 9027), 스타필로코쿠스 아우레우스 (Staphylococcus aureus ; ATCC 6538), 칸디나 알비칸스 (Candida albicans ; ATCC 10231) 및 아스퍼질러스 니거 (Aspergillus niger ; ATCC 16404) 등의 박테리아, 효모 및 곰팡이에 대하여 실시하였다. 각 물질들은 0.01 - 10%의 농도로 트립틱 소이(Tryptic Soy broth) 배지 및 사부로덱스트로스 (SD) 배지에 첨가한 후 배양액을 액상으로 제조하고, 상기한 박테리아, 효모 및 곰팡이균을 접종한 다음 25℃ - 32℃에서 24 - 72 시간 동안 배양하고 균의 상태를 관찰하였다. 접종한 초기의 균수를 현저히 감소시키는 농도를 최소생육저해농도 (MIC)로 하여 항균력을 측정하였으며, 그 결과를 하기 표 1(폴리올 화합물의 항균력)에 나타내었다.The antibacterial activity of the polyol compound of the 1,2-diol structure obtained in Example 1-3 was compared with that of 1,2-hexanediol. The test for the measurement of the antimicrobial activity can be carried out in the following order: Escherichia coli (ATCC 8739), Pseudomonas aeruginosa (ATCC 9027), Staphylococcus aureus (ATCC 6538), Candida albicans 10231) and Aspergillus niger (ATCC 16404). Each substance was added to a Tryptic Soy broth medium and a Sabouraud dextrose (SD) medium at a concentration of 0.01 to 10%, and then the culture broth was prepared as a liquid, and the bacteria, yeast and fungus were inoculated The cells were cultured at 25 ° C - 32 ° C for 24 - 72 hours. The antimicrobial activity was measured using the minimum growth inhibitory concentration (MIC) at a concentration that significantly decreased the initial number of bacteria inoculated. The results are shown in Table 1 (antibacterial activity of polyol compound).

1,2-헥산디올1,2-hexanediol 실시예 1Example 1 실시예 2Example 2 실시예 3Example 3 Escherichia coli (대장균)Escherichia coli (E. coli) 0.90%0.90% 0.23%0.23% 0.22%0.22% 0.24%0.24% Pseudomonus aeruginosaPseudomonus aeruginosa 0.94%0.94% 0.23%0.23% 0.25%0.25% 0.30%0.30% Staphylococcus aureus Staphylococcus aureus 0.86%0.86% 0.33%0.33% 0.24%0.24% 0.21%0.21% Candida albicansCandida albicans 0.90%0.90% 0.24%0.24% 0.26%0.26% 0.21%0.21% Aspergillus nigerAspergillus niger 0.92%0.92% 0.24%0.24% 0.30%0.30% 0.23%0.23%

표 1에서 나타나 있는 것과 같이 실시예 1 - 3의 세가지 화합물 모두 양성 대조군으로 사용한 1,2-헥산디올보다 측정한 다섯 가지의 모든 균에서 높은 항균 활성을 보임을 알 수 있었다.As shown in Table 1, all of the three compounds of Examples 1 to 3 were found to exhibit high antimicrobial activity in all five bacteria measured from 1,2-hexanediol used as a positive control.

[제형예 1] 영양화장수(밀크로션)의 제조[Formulation Example 1] Production of nutritional lotion (milk lotion)

상기 실시예 1 - 3에서 제조한 1,2-디올구조의 폴리올 화합물을 함유하는 영양화장수를 제조하였다.A nutritional lotion containing the polyol compound of the 1,2-diol structure prepared in Example 1-3 was prepared.

성분ingredient 함량(중량 %)Content (% by weight) 1. 정제수One. Purified water 잔량Balance 2. 글리세린2. glycerin 8.08.0 3. 부틸렌글라이콜3. Butylene glycol 4.04.0 4. 히아로론산 추출물4. Hyaluronic acid extract 5.05.0 5. 베타글루칸5. Beta Glucan 7.07.0 6. 카보머6. Carbomer 0.10.1 7. 1,2-디올구조의 폴리올7. A polyol having a 1,2-diol structure 적량Suitable amount 8. 카프릴릭/카프릭 트리글리세라이드8. Caprylic / capric triglyceride 8.08.0 9. 스쿠알렌9. Squalene 5.05.0 10. 세테아릴 글루코사이드10. Cetearyl glucoside 1.51.5 11. 소르비탄 스테아레이트11. Sorbitan stearate 0.40.4 12. 세테아릴 알코올12. Cetearyl alcohol 1.01.0 13. 향13. incense 적량Suitable amount 14. 색소14. Pigment 적량Suitable amount 15. 트리에탄올아민15. Triethanolamine 0.10.1

[제형예 2] 영양크림의 제조[Formulation Example 2] Preparation of nutritional cream

상기 실시예 1 - 3에서 제조한 1,2-디올구조의 폴리올 화합물을 함유하는 영양크림을 제조하였다.A nutritional cream containing the polyol compound of the 1,2-diol structure prepared in Example 1-3 was prepared.

성분ingredient 함량(중량 %)Content (% by weight) 1. 정제수One. Purified water 잔량Balance 2. 글리세린2. glycerin 3.03.0 3. 부틸렌글라이콜3. Butylene glycol 3.03.0 4. 유동파라핀4. Liquid paraffin 7.07.0 5. 베타글루칸5. Beta Glucan 7.07.0 6. 카보머6. Carbomer 0.10.1 7. 1,2-디올구조의 폴리올7. A polyol having a 1,2-diol structure 적량Suitable amount 8. 카프릴릭/카프릭 트리글리세라이드8. Caprylic / capric triglyceride 3.03.0 9. 스쿠알렌9. Squalene 5.05.0 10. 세테아릴 글루코사이드10. Cetearyl glucoside 1.51.5 11. 소르비탄 스테아레이트11. Sorbitan stearate 0.40.4 12. 폴리솔베이트12. Polysorbate 1.21.2 13. 향13. incense 적량Suitable amount 14. 색소14. Pigment 적량Suitable amount 15. 트리에탄올아민15. Triethanolamine 0.10.1

본 발명에 대해 상기 실시예를 참조하고 설명하였으나, 이는 예시적인 것에 불과하며, 본 발명에 속하는 기술분야의 통상의 지식을 가진 자라면 이로부터 다양한 변형 및 균등한 타 실시예가 가능하다는 점을 이해할 것이다. 따라서 본 발명의 진정한 기술적 보호범위는 첨부된 특허 청구 범위의 기술적 사항에 의해 정해져야 할 것이다.While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it will be understood by those of ordinary skill in the art that various modifications and equivalent arrangements may be made therein without departing from the scope of the present invention . Accordingly, the true scope of the present invention should be determined by the technical scope of the appended claims.

Claims (5)

하기 화학식 1로 표시되는 1,2-디올 구조의 폴리올 유도체 화합물:
[화학식 1]
Figure pat00003

상기 식에서, R1은 나이트로전(N) 또는 설퍼(S) 이고, R2는 OH 또는 C2 알킬이다
A polyol derivative compound having a 1,2-diol structure represented by the following formula
[Chemical Formula 1]
Figure pat00003

Wherein R 1 is Nitrogen (N) or Sulfur (S) and R 2 is OH or C 2 alkyl
다음 1 단계 반응을 포함하는 제 1항에 따른 1,2-디올 구조의 폴리올 유도체 화합물의 제조방법:
1) 에폭시 구조를 갖는 글리시돌(Glycidol) 또는 3-클로로-프로판-1,2-디올 (3-Chloro-propane-1,2-diol)과 과량의 에탄올 아민, 부틸아민, 또는 부탄티올을 반응시키는 단계.
A process for producing a polyol derivative compound having a 1,2-diol structure according to claim 1, comprising the following first step reaction:
1) Glycidol or 3-Chloro-propane-1,2-diol with an epoxy structure and excess ethanolamine, butylamine, or butanethiol Lt; / RTI >
제 1항에 따른 1,2-디올 구조의 폴리올 유도체 화합물을 유효성분으로 함유하는 항균 조성물.
An antimicrobial composition comprising the polyol derivative compound of the 1,2-diol structure according to claim 1 as an active ingredient.
제 1항에 따른 1,2-디올 구조의 폴리올 유도체 화합물을 방부제로서 함유하는 피부 외용제 조성물.
A composition for external application for skin comprising a polyol derivative compound having a 1,2-diol structure according to claim 1 as a preservative.
제 4항에 있어서, 상기 피부 외용제는 유연화장수, 수렴화장수, 영양화장수, 아이크림, 영양크림, 마사지크림, 클린징크림, 클린징폼, 클린징워터, 파우더, 에센스, 팩 또는 연고 중 어느 하나의 제형을 갖는 것을 특징으로 하는 피부 외용제 조성물.The composition according to claim 4, wherein the external preparation for skin is at least one selected from the group consisting of a softening agent, a convergent lotion, a nutritional lotion, an eye cream, a nutritional cream, a massage cream, a cleansing cream, a cleansing foam, a cleansing water, a powder, Wherein the external preparation for skin is a composition for external application for skin.
KR1020180006364A 2018-01-18 2018-01-18 1,2-Diol type polyol derivative compound and preparation method thereof and anti-microbial composition containing it KR20190088171A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020180006364A KR20190088171A (en) 2018-01-18 2018-01-18 1,2-Diol type polyol derivative compound and preparation method thereof and anti-microbial composition containing it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020180006364A KR20190088171A (en) 2018-01-18 2018-01-18 1,2-Diol type polyol derivative compound and preparation method thereof and anti-microbial composition containing it

Publications (1)

Publication Number Publication Date
KR20190088171A true KR20190088171A (en) 2019-07-26

Family

ID=67469655

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180006364A KR20190088171A (en) 2018-01-18 2018-01-18 1,2-Diol type polyol derivative compound and preparation method thereof and anti-microbial composition containing it

Country Status (1)

Country Link
KR (1) KR20190088171A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101567299B1 (en) 2014-01-29 2015-11-09 에이치앤비 주식회사 Mask Pack Sheet with Improved Manufacturing Process and Increased Shelf-life and Method for Fabricating Thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101567299B1 (en) 2014-01-29 2015-11-09 에이치앤비 주식회사 Mask Pack Sheet with Improved Manufacturing Process and Increased Shelf-life and Method for Fabricating Thereof

Similar Documents

Publication Publication Date Title
US11306051B2 (en) Use of vanillin derivatives as a preservative, preservation method, compounds, and composition
CN111031794B (en) Antimicrobial mixture containing 4- (3-ethoxy-4-hydroxyphenyl) butan-2-one and organic acid compound, and cosmetic composition containing the same
US20120269739A1 (en) Composition, use, and preservation method
KR20150049027A (en) Composition of preservatives and cosmetic composition comprising the same
KR102272901B1 (en) Composition for external application to the skin containing meso-2,3-butanediol as a preservative
KR102093827B1 (en) Cosmetic compositions containing poly(butyl cyanoacrylate)
KR101945987B1 (en) A preservative comprising tyrosol for skin external application, and a cosmetic composition and a pharmaceutical composition comprising the same
KR20160044071A (en) Preservative composition containing methyl 3-acetyl-4-hydroxybenzoate as an active ingredient
KR102059392B1 (en) Antimicrobial and Antifungal Composition Containing Clove, Hibiscus, and Coconut Extract Complex as Active Ingredient
KR101779131B1 (en) A preservative for skin external application, and a cosmetic composition and a pharmaceutical composition comprising the same
KR101473925B1 (en) Antiseptic compositions comprising Magnolia grandiflora extract and cosmetic compositions containing the same
JP2002212021A (en) Cosmetic
KR102024947B1 (en) Composition containing octyl gallate
KR101585795B1 (en) Preservative composition containing diethylene glycol monobenzyl ether as an active ingredient
KR102061111B1 (en) Antimicrobial composition and manufacturing method thereof
KR101788179B1 (en) Low irritation skin external application composition with an improved antiseptic ability
KR20190088171A (en) 1,2-Diol type polyol derivative compound and preparation method thereof and anti-microbial composition containing it
KR20170002744A (en) Composition of preservatives and cosmetic composition comprising the same
KR20170038582A (en) Antiseptic containing caprylic/capric glycerides and composition for skin external application containing thereof
KR101912418B1 (en) Antibiotic composition with Xylitol derivative and method for production of it
EP3988079A1 (en) Preservative for externally-applied dermal preparation, and cosmetic composition and pharmaceutical composition each comprising same
JP6808447B2 (en) Antibacterial agent
KR102227751B1 (en) Natural antiseptic substitute comprising extraction mixture of Schisandra chinensis, Thymus quinquecostatus and Elsholtzia splendens as effective component and uses thereof
JP7153969B1 (en) antibacterial agent
KR102465358B1 (en) A preservative for skin external application comprising magnolol, honokiol, or a combination thereof, and a cosmetic composition comprising the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application